Shinji Mizuarai - Concepedia

Concepedia

Author

Shinji Mizuarai

Food Research Institute

Also Known As

Mizuarai, Shinji, S Mizuarai, S. Mizuarai, Shinji Mizuarai

52

Publications

3.2K

Citations

18

H-Index

43

Concepts

All Affiliations

Food Research Institute Taiho Pharmaceutical (Japan)The University of Tokyo Nagoya University

SM

About

Shinji Mizuarai is an author at Food Research Institute specializing in medicine, cancer research, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	937
2	Cell Biology	6	6	779
3	Engineering	3	3	126
4	Biomolecular Engineering	1	1	45
5	Biostatistics	1	1	39

Shinji Mizuarai

×

20

Publications

3.2K

Citations

18

H-Index

	Year	Citations
Role of the Toll-like Receptor 4/NF-κB Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages Takayoshi Suganami, Kanami Tanimoto-Koyama, Junko Nishida, Arteriosclerosis Thrombosis and Vascular Biology	2006	793
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents Hiroshi Hirai, Yoshikazu Iwasawa, Megumu Okada, Molecular Cancer Therapeutics Wee1 KinaseOncogenic AgentMedicineTyrosine KinaseReceptor Tyrosine Kinase	2009	540
Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice Kazuhiko Takahashi, Shinji Mizuarai, Hiromitsu Araki, Journal of Biological Chemistry	2003	325
Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2 Shinji Mizuarai, Naohiko Aozasa, Hidehito Kotani International Journal of Cancer	2003	311
MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts N.V. Rajeshkumar, Elizabeth De Oliveira, Niki A. Ottenhof, Clinical Cancer Research	2011	274
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil Hiroshi Hirai, Tsuyoshi Arai, Megumu Okada, Cancer Biology & Therapy	2010	233
Production of Transgenic Quails with High Frequency of Germ-Line Transmission Using VSV-G Pseudotyped Retroviral Vector Shinji Mizuarai, Kenichiro Ono, Kazuhisa Yamaguchi, Biochemical and Biophysical Research Communications Synthetic VirologyGenetic EngineeringVirologyTransgenic QuailsGene Vector	2001	119
Mutant p53 Induces the GEF-H1 Oncogene, a Guanine Nucleotide Exchange Factor-H1 for RhoA, Resulting in Accelerated Cell Proliferation in Tumor Cells Shinji Mizuarai, Kazunori Yamanaka, Hidehito Kotani Cancer Research Mutant P53Tumor BiologyGef-h1 ExpressionAccelerated Cell ProliferationGef-h1 Induction	2006	109
Identification of Dicarboxylate Carrier Slc25a10 as Malate Transporter in de Novo Fatty Acid Synthesis Shinji Mizuarai, Satomi Miki, Hiromitsu Araki, Journal of Biological Chemistry	2005	87
Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor Shinji Mizuarai, Kazunori Yamanaka, Hiraku Itadani, Molecular Cancer	2009	71

Page 1